Purification of posaconazole and of posaconazole intermediates
    3.
    发明授权
    Purification of posaconazole and of posaconazole intermediates 有权
    泊沙康唑和泊沙康唑中间体的纯化

    公开(公告)号:US09206146B2

    公开(公告)日:2015-12-08

    申请号:US13697803

    申请日:2011-05-18

    摘要: The present invention relates to a process for the preparation of a hydrogen chloride (HCl) salt of a compound of formula (I) wherein Y1 and Y2 are independently F or Cl, preferably F, said compound of formula (I) containing the cis-isomer and the trans-isomer, wherein the process comprises (1) providing the compound of formula (I) comprised in a first suitable solvent; and (2) treating the compound of formula (I) comprised in the first suitable solvent with HCl comprised in a second suitable solvent to obtain the HCl salt of the compound of formula (I).

    摘要翻译: 本发明涉及一种制备式(I)化合物的氯化氢(HCl)盐的方法,其中Y1和Y2独立地为F或Cl,优选为F,所述式(I)化合物含有顺式 - 异构体和反式异构体,其中所述方法包括(1)提供包含在第一合适溶剂中的式(I)化合物; 和(2)用包含在第二合适溶剂中的HCl处理包含在第一合适溶剂中的式(I)化合物,得到式(I)化合物的HCl盐。

    IMPROVED PROCESS FOR THE PRODUCTION OF BIMATOPROST
    7.
    发明申请
    IMPROVED PROCESS FOR THE PRODUCTION OF BIMATOPROST 失效
    改进BIMATOPROST生产工艺

    公开(公告)号:US20110178340A1

    公开(公告)日:2011-07-21

    申请号:US12999112

    申请日:2009-06-10

    IPC分类号: C07C405/00

    摘要: The present invention relates to a process for the purification of crude bimatoprost to obtain pure bimatoprost comprising a chromatography, preferably a chromatography using an achiral stationary phase and an eluent comprising an alcohol and an apolar solvent; and crystallisation of the product obtained the chromatography to obtain pure bimatoprost.

    摘要翻译: 本发明涉及纯化比马前列素以获得纯比马前列素的方法,其包括色谱法,优选使用非手性固定相的色谱法和包含醇和非极性溶剂的洗脱液; 并将得到的产物进行结晶,得到纯比马前列素。

    PROCESS FOR THE PRODUCTION OF TELITHROMYCIN
    8.
    发明申请
    PROCESS FOR THE PRODUCTION OF TELITHROMYCIN 审中-公开
    生产丝氨酸蛋白酶的方法

    公开(公告)号:US20110040078A1

    公开(公告)日:2011-02-17

    申请号:US12739194

    申请日:2008-10-10

    IPC分类号: C07H17/08 C07D401/04

    CPC分类号: C07H17/08

    摘要: The present invention relates to a process for the preparation of erythromysin derivatives, in particular telithromycin of formula (I) and its pharmaceutically acceptable salts, providing the isolated intermediates in crystalline form of superior stability and purity.

    摘要翻译: 本发明涉及制备红细菌素衍生物,特别是式(I)的泰利霉素及其药学上可接受的盐的方法,其提供具有优异稳定性和纯度的结晶形式的分离的中间体。